Author:
Zhang Hong-Sheng,Liu Qian,Piao Chun-Mei,Zhu Yan,Li Qiang-Qiang,Du Jie,Gu Hong
Reference25 articles.
1. Galiè N, Humbert M, Vachiery JL, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Kardiol Pol. 2016;73(12):1127.
2. Loyd JE, Atkinson JB, Pietra GG, Virmani R, Newman JH. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. Am Rev Respir Dis. 1988;138(4):952–7.
3. Runo JR, Loyd JE, hypertension P p. Lancet. 2003;361(9368):1533–44.
4. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation. 1999;99(9):1197–208.
5. International PPHC, Lane KB, Machado RD, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet. 2000;26(1):81–4.